EGFR EXON 20 INSERTION MUTATION
Clinical trials for EGFR EXON 20 INSERTION MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR EXON 20 INSERTION MUTATION trials appear
Sign up with your email to follow new studies for EGFR EXON 20 INSERTION MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks Real-Life results of amivantamab combo for tough lung cancer
Knowledge-focused Recruiting nowThis study is watching how well a treatment combining amivantamab and chemotherapy works in everyday medical practice for adults with metastatic non-small cell lung cancer that has certain EGFR gene changes. About 100 people who are already getting this treatment through an early…
Matched conditions: EGFR EXON 20 INSERTION MUTATION
Sponsor: GFPC Investigation • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC
-
Scientists probe resistance to key lung cancer drug
Knowledge-focused Recruiting nowThis study looks at why the drug amivantamab stops working in people with a specific type of advanced lung cancer (NSCLC with EGFR exon 20 insertion). Researchers will collect blood and tumor samples from 30 patients when their disease gets worse. The goal is to find genetic chan…
Matched conditions: EGFR EXON 20 INSERTION MUTATION
Phase: NA • Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC